Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0203 | 8.40927920464 | 0.2414 | 0.3255 | 0.2022 | 3296011 | 0.27674153 | CS |
| 4 | -0.0127 | -4.62827988338 | 0.2744 | 0.3533 | 0.2022 | 3179046 | 0.28169439 | CS |
| 12 | -0.0899 | -25.5688282139 | 0.3516 | 0.515 | 0.138 | 7174184 | 0.2841753 | CS |
| 26 | -0.5023 | -65.7460732984 | 0.764 | 0.89 | 0.138 | 6171618 | 0.41128975 | CS |
| 52 | -8.8463 | -97.1267018006 | 9.108 | 10.8 | 0.138 | 3468401 | 0.7171699 | CS |
| 156 | -325.7783 | -99.919733775 | 326.04 | 971.5156 | 0.138 | 1616108 | 134.64061609 | CS |
| 260 | -27.8191 | -99.0680464944 | 28.0808 | 2640 | 0.138 | 1153153 | 205.39417295 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Premium
